Respiratory

A significant increase in walking pneumonia cases among children, largely attributed to Mycoplasma pneumoniae infections, is drawing attention from U.S. healthcare professionals.

A reported rise in respiratory infections has been issued by the U.S. CDC, particularly Mycoplasma pneumonia and RSV.

The U.S. FDA has approved a wearable device for treating metastatic non-small cell lung cancer in adults. Used with PD-1/PD-L1 inhibitors or docetaxel, it showed a median survival of 13.2 months.

A nationwide study presented at the CHEST Annual Meeting 2024 revealed rising trends in metabolically healthy obesity (MHO) among elderly patients hospitalized for acute exacerbations of chronic obstructive pulmonary disease

A strong link has been identified between the cumulative impact of neighborhood-level environmental and social factors, known as the “neighborhood exposome,” and the prevalence of asthma and COPD in U.S. adults

A new study has shown that the BACES score, a clinical tool used to predict mortality in non-tuberculous mycobacteria (NTM) lung disease, can also help predict treatment outcomes in patients with Mycobacterium avium complex lung disease (MAC-LD)

Pulmonary hypertension is a progressive and potentially fatal condition that can go undetected until it reaches advanced stages. A groundbreaking study presented at the CHEST Annual Meeting 2024 introduces a multimodal fusion model (MMF-PH) that incorporates AI

Findings from two Phase 3 clinical trials, BOREAS and NOTUS, revealed that dupilumab, a monoclonal antibody targeting key drivers of type 2 inflammation, improves health-related quality of life (HRQoL) in patients with chronic obstructive pulmonary disease (COPD)